A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology
Related Experiment Video
Updated: Feb 9, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
Nurver Ulger Toprak1, Alida C M Veloo2, Edit Urban3
1Marmara University School of Medicine, Department of Microbiology, Istanbul, Turkey.
Abstract:
Knowledge about the antimicrobial susceptibility patterns of different Prevotella species is limited. The aim of this study was to determine the current antimicrobial susceptibility of clinical isolates of Prevotella species from different parts of Europe, Kuwait and Turkey. Activity of 12 antimicrobials against 508 Prevotella isolates, representing 19 species, were tested according to Etest methodology. EUCAST, CLSI and FDA guidelines were used for susceptibility interpretations. All Prevotella species were susceptible to piperacillin/tazobactam, imipenem, meropenem, tigecycline and metronidazole. Ampicillin/sulbactam and cefoxitin also showed good activity. Ampicillin, clindamycin, tetracycline and moxifloxacin were less active; 51.2%, 33.7%, 36.8% and 18.3% of isolates were non-susceptible, respectively. A total of 49 (9.6%) isolates were resistant to three or more antimicrobials. Prevotella bivia was the most prevalent species (n = 118) and accounted for most of the multidrug-resistant isolates. In conclusion, the level of non-susceptibility to antimicrobials, which may be used for treatment of infections involving Prevotella species, are a cause of concern. This data emphasizes the need for species level identification of clinical Prevotella isolates and periodic monitoring of their susceptibility to guide empirical treatment.
Insights
Antimicrobial susceptibility testing reveals that while some antibiotics are effective against Prevotella species, others show concerning resistance. This highlights the need for species identification and ongoing monitoring to guide effective treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Limited knowledge exists regarding antimicrobial susceptibility patterns of various Prevotella species.
- Prevotella species are increasingly recognized as significant pathogens in various infections.
Purpose of the Study:
- To determine the current antimicrobial susceptibility profiles of clinical Prevotella isolates across Europe, Kuwait, and Turkey.
- To identify trends in antimicrobial resistance among different Prevotella species.
Main Methods:
- Antimicrobial susceptibility testing was performed on 508 Prevotella isolates from 19 species using Etest methodology.
- Susceptibility interpretations followed EUCAST, CLSI, and FDA guidelines.
Main Results:
- All Prevotella species demonstrated susceptibility to piperacillin/tazobactam, imipenem, meropenem, tigecycline, and metronidazole.
- Ampicillin, clindamycin, tetracycline, and moxifloxacin exhibited lower activity, with significant non-susceptibility rates.
- Prevotella bivia was the most common species, and 9.6% of isolates were multidrug-resistant.
Conclusions:
- The observed non-susceptibility rates to certain antimicrobials are a cause for concern for treating Prevotella infections.
- Species-level identification and regular susceptibility monitoring are crucial for guiding empirical treatment decisions.
More Related Videos
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
12:39Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
Published on: June 24, 2011
Related Concept Videos
Surveys
Introduction to Surveying, Plane Surveying and Geodetic Surveys
What is a Species?
Keystone Species
Formation of Species
Errors and Mistakes in Surveying